期刊文献+

十二指肠-空肠转流手术对2型糖尿病大鼠胰岛素抵抗的改善作用 被引量:3

Amelioration effect of duodenal-jejunal bypass surgery on insulin-resistance in Goto-Kakizaki rats
下载PDF
导出
摘要 目的建立十二指肠-空肠转流手术(duodenal-jejunal bypass surgery,DJB)动物模型,观察术后GK大鼠胰岛素抵抗情况的变化,研究DJB手术治疗2型糖尿病的机理。方法雄性Wistar大鼠为空白对照组;雄性GK大鼠分为模型对照组和DJB手术组。分别于手术后3、6和9周每组随机抽取6只动物进行高胰岛素-正葡萄糖钳夹实验;钳夹实验结束后1周,检测肝脏Gc K、G6P以及PEPCK mRNA表达情况以及骨骼肌细胞膜GLUT4含量变化。结果术后3周和6周,DJB手术组动物的葡萄糖输注率(GIR)较模型对照组差异无显著性(P>0.05),肝脏Gc K、G6P以及PEPCK mRNA表达量较模型对照组差异无显著性(P>0.05);术后9周,DJB手术组动物的葡萄糖输注率(GIR)显著高于模型对照组(P<0.05),肝脏Gc K表达量DJB手术组显著高于模型对照组(P<0.05),而G6P以及PEPCK mRNA表达量显著低于模型对照组(P<0.05);DJB手术后3、6和9周,DJB手术组骨骼肌细胞膜GLUT4的含量较模型对照组差异无显著性(P>0.05)。结论 DJB手术改善血糖的水平是通过改善体内肝脏组织的胰岛素抵抗,通过调节糖代谢酶的表达,进而提高肝脏葡萄糖摄取并抑制肝脏糖异生作用。在实验周期内,DJB手术对于骨骼肌组织的胰岛素抵抗未发现有明显改善,提示DJB手术治疗2型糖尿病的效果与时间有一定关系。 Objective To establish a Goto-Kakizaki ( GK) rat model of duodenal-jejunal bypass( DJB) and ob-serve the changes in insulin-resistance after surgery, and to explore the mechanism of DJB surgery in treatment of type 2 di-abetes mellitus.Methods Male Goto-kakizaki diabetic rats(GK,n=36)were used as experiment group and 18 healthy male Wistar rats as blank group.GK rats were randomly divided into two groups: diabetic control group and DJB surgery group ( n=18) .Euglycemic-hyperinsulinemic clamp technique was performed in 6 rats randomly taken from each group at third week, sixth week and ninth week after surgery, respectively.The expression levels of Gck, G6P, PEPCK mRNA in the liver and GLUT4 content on skeletal muscle cell plasma membrance were detected one week after the clamp test. Results In the DJB surgery group at the end of third week and sixth week after surgery, the levels of glucose infusion rates and the expression levels of Gck, G6P, PEPCK mRNA in the liver showed no statistically significant difference as com-pared with the diabetic control group (P〉0.05).In the DJB surgery group at the end of 9th week after surgery, the glu-cose infusion rate and expression level of Gck mRNA in the liver were significantly higher, and the expression of G6P and PEPCK mRNA was significantly lower than those in the diabetic control group ( P〈0.05 for all) .At the three time points (3rd week, 6th week and 9th week after surgery), there was no significant difference in the GLUT4 content on skeletal muscle cell plasma membrane between the diabetic control group and DJB surgery group ( P〉0.05 for all) .Conclusions Our results indicate that the mechanism of DJB surgery improving blood glucose level may be closely related to the amel-ioration of insulin-resistance in the liver, thereby augmenting glucose uptake and inhibiting gluconeogenesis in liver through the regulation of glucose metabolism-related enzymes.There is no significant improvement in insulin-resistance in the skele-tal muscles during the experiment period.This result implies that the effect of DJB surgery on type 2 diabetes is related to the duration of therapy.
出处 《中国实验动物学报》 CAS CSCD 北大核心 2015年第2期159-164,共6页 Acta Laboratorium Animalis Scientia Sinica
基金 上海市科学技术委员会科研计划项目(No.11140900702)
关键词 2型糖尿病 GK大鼠 十二指肠-空肠转流术 高胰岛素-正葡萄糖钳夹实验 Type 2 diabetes mellitus Goto-Kakizaki rats Duodenal-jejunal bypass surgery Euglycemic-hyperin-sulinemic clamp technique Insulin resistance
  • 相关文献

参考文献22

  • 1Suzuki R, Tobe K, Aoyama M, et al. Both insulin signaling de-fects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2-/- mice [J], J Biol Chem. 2004, 279 (24) : 25039 - 25049.
  • 2Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes : a new perspective for an old disease [J]. Ann Surg. 2004, 239(1): 1-11.
  • 3de Luis D, Domingo M, Romero A, et al. Effects of duodenal- jejunal exclusion on beta cell function and hormonal regulation in Goto-Kakizaki rats [ J ]. Am J Surg. 2012, 204 (2) : 242 - 247.
  • 4Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 di- abetes [J]. Ann Surg. 2006, 244(5): 741 -749.
  • 5朱慧丽,翁泽平,林琛莅,马继伟,钟雪云.GLP-1通过下调ATGL表达参与3T3-L1脂肪细胞脂质代谢[J].南方医科大学学报,2013,33(10):1499-1503. 被引量:9
  • 6赵先哲,乔伟伟.GK糖尿病大鼠发病机理的研究进展[J].实验动物与比较医学,2011,31(2):140-146. 被引量:2
  • 7赵先哲,乔伟伟.表没食子儿茶素没食子酸酯对大鼠胰岛素抵抗的影响[J].中国实验动物学报,2011,19(6):489-494. 被引量:3
  • 8Castagneto-Gissey L, Mingrone G. Insulin sensitivity and secre- tion modifications after bariatric surgery [ J]. J Endocrinol Inves- tig, 2012, 35(7) : 692 -698.
  • 9Cho H, Mu J, Kim JK, et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta) [J]. Science, 2001, 292(5522): 1728-1731.
  • 10Lee YS, Park MS, Cboung JS, et al. Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes [ J]. Diabetologia, 2012, 55 (9) : 2456 -2468.

二级参考文献41

  • 1Lee K U,Diabetologia,1988年,31卷,285页
  • 2Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta[J]. Science, 2001, 293(5535): 1673-7.
  • 3Umpierrez GE, Meneghini L. Reshaping diabetes care: the fundamental role of DPP-4 inhibitors and and glucagon-like GLP-1 receptor agonists in clinical practice[J]. Endocr Pract, 2013, 19(4): 718-28.
  • 4Kim Chung le T, Hosaka T, Yoshida M, et al. Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression [J]. Biochem Biophys Res Commun, 2009, 390(3): 613-8.
  • 5Lee YS, Park MS, Choung JS, et al. Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes [J]. Diabetologia, 2012, 55(9): 2456-68.
  • 6Daousi C, Pinkney JH, Cleator J, et al. Acute peripheral administration of synthetic human GLP-1 (7-36 amide) decreases circulating IL-6 in obese patients with type 2 diabetes mellitus: A potential role for GLP-1 in modulation of the diabetic pro-inflammatory state[J]. Regul Pept, 2013, 183C: 54-61.
  • 7Abel ED, Peroni O, Kim JK, et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver[J]. Nature, 2001, 409(6821): 729-33.
  • 8Chakrabarti P, Kandror KV. FoxO1 controls insulin-dependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes[J]. J Biol Chem, 2009, 284(20): 13296-300.
  • 9McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes[J]. Diabetes, 2002, 51 (1): 7-18.
  • 10Kralisch S, Klein J, Lossner U, et al. Isoproterenol, TNFalpha, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytes[J]. Mol Cell Endocrinol, 2005, 240(1-2): 43-9.

共引文献56

同被引文献18

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部